Literature DB >> 26501211

Epidemiology of Sarcoidosis in a Prospective Cohort Study of U.S. Women.

Orianne Dumas1,2, Lisa Abramovitz1, Aleta S Wiley1, Yvette C Cozier3, Carlos A Camargo1,2.   

Abstract

RATIONALE: Sarcoidosis is a systemic granulomatous and inflammatory disorder that most often involves the lungs but also affects many other organs. Data on sarcoidosis from large epidemiological studies remain scarce.
OBJECTIVES: To evaluate the baseline prevalence and 22-year incidence of sarcoidosis and their associations with demographic and geographic characteristics in a large cohort of U.S. women.
METHODS: The Nurses' Health Study II is a prospective cohort study of U.S. female nurses enrolled in 1989 (aged 25-44 yr, n = 116,430). Data on major illnesses were collected through biennial questionnaires (1989-2011). Cases were identified by the nurses' self-report of physician-diagnosed sarcoidosis. Associations of demographic and geographic characteristics with sarcoidosis were evaluated by logistic regression and Cox models.
MEASUREMENTS AND MAIN RESULTS: A total of 377 sarcoidosis cases were identified. The baseline prevalence was 100/100,000 women. The average annual incidence rate was 11/100,000 during 2,275,028 person-years of follow up. Incidence rate increased with age (P = 0.003), from 9 to 15/100,000 in women aged less than 35 to 55 or more years, respectively. Black women had a higher prevalence (odds ratio, 5.24; 95% confidence interval, 2.87-9.55) and incidence (hazard ratio, 3.80; 95% confidence interval, 2.31-6.24) than white women. Across U.S. regions, more than twofold differences were observed in sarcoidosis prevalence and incidence, with consistently higher rates in the Northeast.
CONCLUSIONS: We provide recent national data on the epidemiology of sarcoidosis among U.S. women. Important differences in prevalence and incidence were observed across U.S. regions. Large epidemiological studies are needed to better understand the causes of the observed demographic and geographic differences in sarcoidosis.

Entities:  

Keywords:  epidemiology; incidence; lung diseases; prevalence

Mesh:

Year:  2016        PMID: 26501211      PMCID: PMC4722845          DOI: 10.1513/AnnalsATS.201508-568BC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  35 in total

1.  Occupational risk factors for sarcoidosis in African-American siblings.

Authors:  Gena P Kucera; Benjamin A Rybicki; Kandace L Kirkey; Steven W Coon; Marcie L Major; Mary J Maliarik; Michael C Iannuzzi
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

2.  A current assessment of rurally linked exposures as potential risk factors for sarcoidosis.

Authors:  D K Kajdasz; D T Lackland; L C Mohr; M A Judson
Journal:  Ann Epidemiol       Date:  2001-02       Impact factor: 3.797

3.  What comorbidities accompany sarcoidosis? A large cohort (n=1779) patients analysis.

Authors:  Magdalena M Martusewicz-Boros; Piotr W Boros; Elżbieta Wiatr; Kazimierz Roszkowski-Śliż
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2015-07-22       Impact factor: 0.670

4.  Prospective study of body mass index, weight change, and risk of adult-onset asthma in women.

Authors:  C A Camargo; S T Weiss; S Zhang; W C Willett; F E Speizer
Journal:  Arch Intern Med       Date:  1999-11-22

5.  Clinical characteristics of patients in a case control study of sarcoidosis.

Authors:  R P Baughman; A S Teirstein; M A Judson; M D Rossman; H Yeager; E A Bresnitz; L DePalo; G Hunninghake; M C Iannuzzi; C J Johns; G McLennan; D R Moller; L S Newman; D L Rabin; C Rose; B Rybicki; S E Weinberger; M L Terrin; G L Knatterud; R Cherniak
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

6.  Geographic variation of MS incidence in two prospective studies of US women.

Authors:  M A Hernán; M J Olek; A Ascherio
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

7.  Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients.

Authors:  Keld-Erik Byg; Nils Milman; Stig Hansen
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2003-03       Impact factor: 0.670

8.  The diagnostic pathway to sarcoidosis.

Authors:  Marc A Judson; Bruce W Thompson; David L Rabin; Joanne Steimel; Genell L Knattereud; Daniel T Lackland; Cecile Rose; Cynthia S Rand; Robert P Baughman; Alvin S Teirstein
Journal:  Chest       Date:  2003-02       Impact factor: 9.410

9.  Sarcoidosis presenting in patients older than 50 years.

Authors:  Roberta Lenner; Gregory J Schilero; Maria L Padilla; Alvin S Teirstein
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2002-06       Impact factor: 0.670

10.  Sarcoidosis: epidemiology and prognosis. A 15-year European study.

Authors:  G Hillerdal; E Nöu; K Osterman; B Schmekel
Journal:  Am Rev Respir Dis       Date:  1984-07
View more
  23 in total

Review 1.  Disease Burden and Variability in Sarcoidosis.

Authors:  Alicia K Gerke; Marc A Judson; Yvette C Cozier; Daniel A Culver; Laura L Koth
Journal:  Ann Am Thorac Soc       Date:  2017-12

2.  Outcome of pulmonary sarcoidosis: a population-based study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eva M Carmona; Eric L Matteson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.

Authors:  Bryan S Benn; Zoe Lehman; Sharon A Kidd; Melissa Ho; Sara Sun; Joris Ramstein; Nicholas K Arger; Christine P Nguyen; Robert Su; Antonio Gomez; Jeffrey M Gelfand; Laura L Koth
Journal:  Lung       Date:  2017-07-13       Impact factor: 2.584

4.  Reliability of Cardiovascular Risk Calculators to Estimate Accurately the Risk of Cardiovascular Disease in Patients With Sarcoidosis.

Authors:  Patompong Ungprasert; Eric L Matteson; Cynthia S Crowson
Journal:  Am J Cardiol       Date:  2017-06-15       Impact factor: 2.778

Review 5.  Gastrointestinal and Hepatic Sarcoidosis: A Review Article.

Authors:  Neil Shah; Arnab Mitra
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

6.  Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

7.  Sarcoidosis-associated Hospitalizations in the United States, 2002 to 2012.

Authors:  Aprielle B Wills; Jennifer Adjemian; Joseph R Fontana; Claudia A Steiner; Shelby Daniel-Wayman; Kenneth N Olivier; D Rebecca Prevots
Journal:  Ann Am Thorac Soc       Date:  2018-12

8.  Association between sarcoidosis, pulse wave velocity, and other measures of subclinical atherosclerosis: a systematic review and meta-analysis.

Authors:  Wai Chung Yong; Anawin Sanguankeo; Sikarin Upala
Journal:  Clin Rheumatol       Date:  2017-11-25       Impact factor: 2.980

9.  Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Med       Date:  2017-08       Impact factor: 10.057

10.  Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Douglas A Simonetto; Eric L Matteson
Journal:  Am J Gastroenterol       Date:  2017-09-05       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.